Neurogenetics Unit, Department of Neurology, Eginition Hospital, University of Athens, 74 Vas. Sofias Av., 11528 Athens, Greece.
Parkinsonism Relat Disord. 2012 Nov;18(9):1027-8. doi: 10.1016/j.parkreldis.2012.05.020. Epub 2012 Jun 12.
In recent years two association studies investigating the HAP1 T441M (rs4523977) polymorphism as a potential modifying factor of the age at onset (AAO) of Huntington's disease (HD), have been reported. Initially evidence for association was found between the M441 risk allele and the AAO. Subsequently, a second study, although failing to replicate these findings, found evidence for association between the same risk allele and AAO of motor symptoms (mAAO). In the present study, the role of the HAP1 T441M polymorphism as a modifier of the AAO in HD was investigated in a cohort of 298 Greek HD patients. In this cohort the CAG repeat number accounted for 55% of the variance in AAO. No association was found between the HAP1 T441M polymorphism and the AAO of HD.
近年来,有两项针对 HAP1 T441M(rs4523977)多态性作为亨廷顿病(HD)发病年龄(AAO)潜在修饰因子的关联研究报告。最初发现 M441 风险等位基因与 AAO 之间存在关联证据。随后,第二项研究虽然未能复制这些发现,但发现相同风险等位基因与运动症状的 AAO(mAAO)之间存在关联证据。在本研究中,在 298 名希腊 HD 患者的队列中研究了 HAP1 T441M 多态性作为 HD AAO 修饰因子的作用。在该队列中,CAG 重复数占 AAO 变异的 55%。未发现 HAP1 T441M 多态性与 HD 的 AAO 之间存在关联。